0002008210-25-000004.txt : 20250806 0002008210-25-000004.hdr.sgml : 20250806 20250806164802 ACCESSION NUMBER: 0002008210-25-000004 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(1) ITEM INFORMATION: Section 3(c)(5) FILED AS OF DATE: 20250806 DATE AS OF CHANGE: 20250806 EFFECTIVENESS DATE: 20250806 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NexPoint Life Sciences III DST CENTRAL INDEX KEY: 0002008210 ORGANIZATION NAME: EIN: 883907129 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-503969 FILM NUMBER: 251190392 BUSINESS ADDRESS: STREET 1: 300 CRESCENT COURT STREET 2: SUITE 700 CITY: DALLAS STATE: TX ZIP: 75201 BUSINESS PHONE: (833) 697-6246 MAIL ADDRESS: STREET 1: 300 CRESCENT COURT STREET 2: SUITE 700 CITY: DALLAS STATE: TX ZIP: 75201 D/A 1 primary_doc.xml X0708 D/A LIVE 0002008210 NexPoint Life Sciences III DST 300 CRESCENT COURT SUITE 700 DALLAS TX TEXAS 75201 (833) 697-6246 DELAWARE None None Other Delaware Statutory Trust true 2023 N/A NexPoint Real Estate Advisors IV, L.P. 300 Crescent Court Suite 700 Dallas TX TEXAS 75201 Executive Officer Sponsor of the Issuer Brian Mitts 300 Crescent Court Suite 700 Dallas TX TEXAS 75201 Executive Officer Authorized Signatory of the Issuer Matt McGraner 300 Crescent Court Suite 700 Dallas TX TEXAS 75201 Executive Officer Authorized Signatory of the Issuer N/A NREA LS III Manager, LLC 300 Crescent Court Suite 700 Dallas TX TEXAS 75201 Executive Officer Manager and Signatory Trustee of the Issuer N/A NREA LS III Contributor, LLC 300 Crescent Court Suite 700 Dallas TX TEXAS 75201 Executive Officer Contributor of the Issuer Other Real Estate Decline to Disclose 06c 3C 3C.1 3C.5 true 0002008210-25-000003 2024-01-25 false true true false 100000 Aurora Securities 46147 None None 2565 West Maple Troy MI MICHIGAN 48084 WA WASHINGTON false Emerson Equity LLC 130032 None None 155 Bovet Road Suite 725 San Mateo CA CALIFORNIA 94402 CA CALIFORNIA CO COLORADO FL FLORIDA WA WASHINGTON false DFPG Investments, LLC 155576 None None 9017 S. Riverside Drive Suite 210 Sandy UT UTAH 84070 CA CALIFORNIA OR OREGON PA PENNSYLVANIA false Arkadios Capital 282710 None None 2827 Peachtree Rd NE Suite 510 Atlanta GA GEORGIA 30305 CA CALIFORNIA FL FLORIDA PA PENNSYLVANIA false Realized Financial, Inc. 22333 None None 400 W. 15th St. Suite 700 Austin TX TEXAS 78701 AZ ARIZONA CO COLORADO MN MINNESOTA OK OKLAHOMA OR OREGON TX TEXAS WA WASHINGTON false IBN Financial Services, Inc. 42360 None None 404 Old Liverpool Rd Liverpool NY NEW YORK 13088 ME MAINE false Great Point Capital LLC 114203 None None 200 West Jackson Blvd. Suite 1000 Chicago IL ILLINOIS 60606 CA CALIFORNIA IL ILLINOIS MA MASSACHUSETTS false Centaurus Financial, Inc. 30833 None None 2300 E. Katella Avenue Suite #200 Anaheim CA CALIFORNIA 92806 CA CALIFORNIA MD MARYLAND NC NORTH CAROLINA false Creativeone Securities, LLC 152974 None None 6330 Sprint Parkway Suite 400 Overland Park KS KANSAS 66211 AZ ARIZONA CA CALIFORNIA false American Trust Investment Services, Inc. 3001 None None 1244 119th Street Whiting IN INDIANA 46394-1003 CA CALIFORNIA MA MASSACHUSETTS NV NEVADA WI WISCONSIN false Independent Financial Group, LLC 7717 None None 12671 High Bluff Drive Suite 200 San Diego CA CALIFORNIA 92130 CA CALIFORNIA HI HAWAII KS KANSAS MN MINNESOTA NM NEW MEXICO false Westpark Capital, Inc. 39914 None None 1800 Century Park East Suite 220 Los Angeles CA CALIFORNIA 90067 CA CALIFORNIA false Saxony Securities, Inc. 115547 None None 11152 S. Towne Square St. Louis MO MISSOURI 63123 MD MARYLAND false FNEX Capital, LLC 166316 None None One Indiana Square Suite 2252 Indianapolis IN INDIANA 46204 CA CALIFORNIA false Realta Equities, Inc. 23769 None None 12636 High Bluff Drive Suite 300 San Diego CA CALIFORNIA 92130 IL ILLINOIS false 30661253 14150789 16510464 Regarding Item 11, the Issuer may accept smaller investments in the Sponsor's sole discretion. false 59 2682859 true 0 true Sales Commissions include estimates of the maximum amount of Selling Commissions and Dealer Fees that may be paid. 761468 true Item 16 is an estimate of offering expenses and acquisition fees that may accrue to one or more Related Persons. false NexPoint Life Sciences III DST /s/Paul A. Richards Paul A. Richards Authorized Signatory of the Issuer 2025-08-06